Parallel Advisors »

Revance Therapeutics shares owned by Parallel Advisors

Quarter-by-quarter ownership of Revance Therapeutics (RVNC) shares owned by Parallel Advisors from 13F filings

Historical chart of Parallel Advisors investment in Revance Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Revance Therapeutics held by Parallel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Revance Therapeutics by Parallel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.9k 327 8.79
2023-03-31 $353 11 32.18
2021-12-31 $5.0k 308 16.23
2021-09-30 $65k 2.2k 29.68
2021-06-30 $65k 2.2k 29.68
2020-09-30 $10k 383 26.11
2020-06-30 $9.0k 383 23.50
2020-03-31 $5.0k 383 13.05
2019-12-31 $6.0k 383 15.67
2019-09-30 $5.0k 383 13.05
2019-06-30 $2.0k 153 13.07